COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases
Although most autoimmune diseases are considered to be CD4 T cell-or antibody-mediated,
many respond to CD20-depleting antibodies that have limited influence on CD4 and plasma …
many respond to CD20-depleting antibodies that have limited influence on CD4 and plasma …
[HTML][HTML] Innate and adaptive immune responses against coronavirus
Coronaviruses (CoVs) are a member of the Coronaviridae family with positive‐sense single-
stranded RNA. In recent years, the CoVs have become a global problem to public health …
stranded RNA. In recent years, the CoVs have become a global problem to public health …
Effects of the COVID-19 pandemic on supply and use of blood for transfusion
SJ Stanworth, HV New, TO Apelseth… - The Lancet …, 2020 - thelancet.com
The COVID-19 pandemic has major implications for blood transfusion. There are uncertain
patterns of demand, and transfusion institutions need to plan for reductions in donations and …
patterns of demand, and transfusion institutions need to plan for reductions in donations and …
Safety, tolerability, and pharmacokinetics of remdesivir, an antiviral for treatment of COVID‐19, in healthy subjects
R Humeniuk, A Mathias, H Cao… - Clinical and …, 2020 - Wiley Online Library
Remdesivir (RDV), a single diastereomeric monophosphoramidate prodrug that inhibits viral
RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory …
RNA polymerases, has potent in vitro antiviral activity against severe acute respiratory …
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and …
COVID‐19 is highly contagious pathogenic viral infection initiated from Wuhan seafood
wholesale market of China on December 2019 and spread rapidly around the whole world …
wholesale market of China on December 2019 and spread rapidly around the whole world …
[HTML][HTML] Revealing the targets and mechanisms of vitamin A in the treatment of COVID-19
R Li, K Wu, Y Li, X Liang, WKF Tse, L Yang… - Aging (albany …, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus
disease 2019 (COVID-19), an epidemic disease characterized by rapid infection and a high …
disease 2019 (COVID-19), an epidemic disease characterized by rapid infection and a high …
The immune system as a target for therapy of SARS-CoV-2: a systematic review of the current immunotherapies for COVID-19
AH Mansourabadi, M Sadeghalvad… - Life sciences, 2020 - Elsevier
Aims The immune response is essential for the control and resolution of viral infections.
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
Following the outbreak of novel coronavirus disease (COVID-19), several immunotherapies …
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
The outbreak of coronavirus disease 2019 (COVID‐19) and pandemic, caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has become a major concern …
Antibody-based immunotherapeutics and use of convalescent plasma to counter COVID-19: advances and prospects
ABSTRACT Introduction Coronavirus disease 2019 (COVID-19) has spread to several
countries globally. Currently, there is no specific drug or vaccine available for managing …
countries globally. Currently, there is no specific drug or vaccine available for managing …
COVID‐19 and headache: a primer for trainees
SM Bobker, MS Robbins - Headache: The Journal of Head and …, 2020 - Wiley Online Library
Objective To summarize for the trainee audience the possible mechanisms of headache in
patients with COVID‐19 as well as to outline the impact of the pandemic on patients with …
patients with COVID‐19 as well as to outline the impact of the pandemic on patients with …